Advertisement

Reactions Weekly

, Volume 1714, Issue 1, pp 25–25 | Cite as

Alemtuzumab/fingolimod

Severe activation of relapsing-remitting multiple sclerosis: 3 case reports
Case report

Reference

  1. Wehrum T, et al. Activation of disease during therapy with alemtuzumab in 3 patients with multiple sclerosis. Neurology 90: e601-e605, No. 7, 13 Feb 2018. Available from: URL: http://doi.org/10.1212/WNL.0000000000004950 - GermanyCrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations